Royalty Pharma published press releases by date and/or category

Avillion Announces Royalty Pharma Investment

Jim Reddoch, PhD, Royalty Pharma Executive Vice President for Research and Investments Joins Avillion Board. London (UK) and New York, NY (US) – May 6, 2014  — Avillion LLP, a company focused on co-development and financing of late-stage pharmaceutical candidates from Phase 3 clinical development

Royalty Pharma Raises $600 Million of Debt

New York, NY (US) – May 24, 2012  — Royalty Pharma, the industry leader in acquiring royalty interests in marketed and late stage biopharmaceutical products, announced that it has successfully issued $600 million of incremental Term Loan B debt through RPI Finance Trust (“RPIFT”), bringing total

Stay up to date

Subscribe to Royalty Pharma news and alerts